- Home
- NVCT vs OCCI Comparison
NVCT vs OCCI Comparison
Compare NVCT & OCCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCT
- OCCI
- Stock Information
- Founded
- NVCT 2020
- OCCI N/A
- Country
- NVCT United States
- OCCI United States
- Employees
- NVCT N/A
- OCCI N/A
- Industry
- NVCT Medicinal Chemicals and Botanical Products
- OCCI Trusts Except Educational Religious and Charitable
- Sector
- NVCT Health Care
- OCCI Finance
- Exchange
- NVCT Nasdaq
- OCCI Nasdaq
- Market Cap
- NVCT 170.3M
- OCCI 146.8M
- IPO Year
- NVCT 2022
- OCCI N/A
- Fundamental
- Price
- NVCT $8.87
- OCCI $6.44
- Analyst Decision
- NVCT Strong Buy
- OCCI
- Analyst Count
- NVCT 3
- OCCI 0
- Target Price
- NVCT $15.67
- OCCI N/A
- AVG Volume (30 Days)
- NVCT 128.2K
- OCCI 115.8K
- Earning Date
- NVCT 05-06-2025
- OCCI 12-11-2023
- Dividend Yield
- NVCT N/A
- OCCI 24.32%
- EPS Growth
- NVCT N/A
- OCCI N/A
- EPS
- NVCT N/A
- OCCI N/A
- Revenue
- NVCT N/A
- OCCI N/A
- Revenue This Year
- NVCT N/A
- OCCI N/A
- Revenue Next Year
- NVCT N/A
- OCCI $10.19
- P/E Ratio
- NVCT N/A
- OCCI N/A
- Revenue Growth
- NVCT N/A
- OCCI N/A
- 52 Week Low
- NVCT $4.44
- OCCI $5.47
- 52 Week High
- NVCT $11.80
- OCCI $10.15
- Technical
- Relative Strength Index (RSI)
- NVCT 51.36
- OCCI 48.76
- Support Level
- NVCT $8.70
- OCCI $6.23
- Resistance Level
- NVCT $10.19
- OCCI $6.70
- Average True Range (ATR)
- NVCT 0.93
- OCCI 0.32
- MACD
- NVCT -0.08
- OCCI 0.07
- Stochastic Oscillator
- NVCT 40.45
- OCCI 81.94
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.